DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 108 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,742,450 | +12.1% | 1,935,000 | +9.0% | 0.18% | +64.5% |
Q2 2023 | $21,188,903 | +13.2% | 1,774,615 | +26.8% | 0.11% | -12.3% |
Q1 2023 | $18,711,957 | -37.9% | 1,399,548 | 0.0% | 0.12% | -49.2% |
Q4 2022 | $30,118,273 | +21.7% | 1,399,548 | +13.3% | 0.24% | +51.9% |
Q3 2022 | $24,749,000 | +42.3% | 1,235,575 | +27.2% | 0.16% | +54.9% |
Q2 2022 | $17,393,000 | – | 971,696 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |